Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Zantac Lawsuits in Delaware State Court Cleared To Move Forward Nearly 75,000 lawsuits over cancer caused by Zantac can proceed, after Delaware state court judge found that plaintiffs’ expert witness testimony was sufficient for a jury to consider the claims June 3, 2024 Irvin Jackson Add Your Comments A Delaware judge has ruled that GlaxoSmithKline, Boehringer Ingelheim, Sanofi and other drug makers must face tens of thousands of Zantac cancer lawsuits in that state’s courts, after rejecting the drug makers’ efforts to have plaintiffs’ expert witnesses barred from testifying at trial. The decision follows three days of hearings, where parties presented arguments to Delaware Judge Vivian L. Medinilla over whether the expert testimony needed to establish that each plaintiff’s cancer diagnosis was caused by Zantac is sufficiently reliable for a jury to consider. Judge Medinilla is overseeing all lawsuits pending in Delaware state court that stem from a massive Zantac recall issued in 2019, after it was discovered that the active pharmaceutical ingredient, ranitidine, is inherently unstable and produces high levels of the chemical byproduct N-Nitrosodimethylamine (NDMA), which is a potent human carcinogen. Plaintiffs allege that the drug makers knew or should have known about the Zantac cancer risks, yet continued to market and sell the drug without any warnings. The lawsuits include claims for individuals who developed bladder cancer, liver cancer, colon cancer, pancreatic cancer, stomach cancer and other injuries long-term use of the heartburn drug. ZANTAC LAWSUITS Did you or a loved one take recalled Zantac? Side effects of Zantac may increase the risk of cancer, due to chemical impurities found in the heartburn drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ZANTAC LAWSUITS Did you or a loved one take recalled Zantac? Side effects of Zantac may increase the risk of cancer, due to chemical impurities found in the heartburn drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION For several years most of the litigation was focused in the federal court system, where all Zantac lawsuits were centralized before Judge Robin L. Rosenberg in the U.S. District Court for the Southern District of Florida, for coordinated discovery and pretrial proceedings. However, in 2022 Judge Rosenberg issued a controversial ruling, determining that all of the plaintiffs’ expert witnesses were excluded from testifying at trial under federal evidentiary rules. While appeals have been filed to challenge Judge Rosenberg’s ruling, the decision has left federal plaintiffs without any means of proving the recalled Zantac pills caused their cancer, and all Zantac lawsuits pending in the federal court system have been dismissed. However, the federal ruling did not have any impact on lawsuits filed in various state courts, where different standards for the admissibility of expert witness testimony apply. Although Zantac manufacturers like Pfizer and Sanofi have already agreed to pay hundreds of millions to settle claims over their role in the development and sale of the drug, nearly 75,000 Zantac lawsuits remain unresolved, most of which are currently pending in Delaware state court. Judge Rejects Motion to Dismiss Plaintiffs’ Expert Witnesses Following three days of Daubert hearings, meant to test whether expert testimony is scientifically sound and relevant to the litigation, Judge Medinilla issued an omnibus order (PDF) rejecting defendants’ efforts to have plaintiffs’ witnesses excluded. Had she dismissed the expert witnesses, plaintiffs would have had no way to prove causation, effectively killing the litigation, which is what occurred at the federal level. “Plaintiffs in this litigation were not before the federal MDL Court. Nor are the experts the same,” Judge Medinilla wrote. “Plaintiffs here are pursuing ten cancers—bladder, esophageal, gastric, liver, pancreatic, breast, colorectal, kidney, lung and prostate. Thus, five of the cancer claims here were not before the MDL Court.” She notes that defendants rely on an FDA study released in July 2021, which did not support that ranitidine converted to NDMA in a “general, healthy population.” “This does little to advance their arguments. If that were the only issue here, that study might have some utility,” the Judge determined. “Zantac was not marketed to serve a generally healthy population.” She indicated that GSK’s marketing efforts appear to have focused on off-label promotion of long-term use for Zantac at the very start, even though it was only approved for short-term use. Both GlaxoSmithKline and Sanofi have issued statements indicating they disagree with the decision. GlaxoSmithKline indicates it plans to appeal the ruling. Zantac Lawsuit Settlements The decision means that the tens of thousands of Zantac lawsuits filed in Delaware can continue to move forward toward trial, unless they are resolved through settlement agreements or other means. In early April 2024, Sanofi announced a Zantac settlement that resolves about 4,000 claims pending outside of Delaware state court, for an estimated payment of about $100 million. Weeks later, a massive Pfizer Zantac settlement was announced to resolve another 10,000 claims for $250 million. However, GlaxoSmithKline and Boehringer Ingelheim continue to face the majority of the remaining claims. Since the drug makers failed to convince Judge Medinilla to exclude all of the plaintiffs’ expert witnesses, it is expected that a steady stream of additional claims will go before juries in the coming years unless those drug makers agree to voluntarily make Zantac cancer payouts to settle claims. Tags: Cancer, Delaware, GlaxoSmithKline, Heartburn, Heartburn Drug, NDMA, Pfizer, Sanofi, Zantac, Zantac Recall More Zantac Lawsuit Stories Jury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim February 5, 2025 Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California November 22, 2024 GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers October 10, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: today) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025) Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 3 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (Posted: 4 days ago) A Mississippi woman’s Ozempic lawsuit indicates that she suffered stomach paralysis due to the drug’s delayed gastric emptying side effects, which left her with permanent injuries. MORE ABOUT: OZEMPIC LAWSUITCourt Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025)GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)
GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers October 10, 2024
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: today) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 3 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer.
Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (Posted: 4 days ago) A Mississippi woman’s Ozempic lawsuit indicates that she suffered stomach paralysis due to the drug’s delayed gastric emptying side effects, which left her with permanent injuries. MORE ABOUT: OZEMPIC LAWSUITCourt Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025)GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)